ArticlePDF Available

The role of the fern test in the treatment of rhinitis

Authors:

Abstract and Figures

Background: The fern test is a method for assessing the characteristics of the nasal section in the treatment of patients with mucous dysfunction of the airway. Objective: The aim of this study was to investigate the role of the fern test in patients with rhinitis and to assess the classification of each type of rhinitis (types I-IV) in clinical practice. Methods: A cross-sectional study, which included consecutive patients from a third level Rhinology Unit, worked with 182 patients with rhinitis and 30 healthy subjects as control. The patients were subdivided according to their type of rhinitis: allergic rhinitis (59), infectious rhinitis (32), polyps (31), NARES (Non-allergic rhinitis with eosinophilia syndrome) (30) and NARNE (non-allergic rhinitis with neutrophils) (30). Results: The control subjects had only type I or II rhinitis, whereas patients with rhinitis usually showed type III or IV. Allergic rhinitis and nasal polyps had the most serious deterioration according to the fern test (type IV). Conclusions: The fern test is effective for assessing mucus alterations in patients with rhinitis and it could be included as a new parameter in the study of rhinitis as a potential biomarker of the function of damaged epithelial cells.
Content may be subject to copyright.
http://www.revistaalergia.mx
184 Rev Alerg Mex. 2019;66(2):184-191
éergia M
Revista
Al xico
Colegio
Mexicano de
Inmunología
Clínica A.C.
Original article
The role of the fern test in the treatment of rhinitis
El papel de la prueba de “helecho” en el tratamiento
de la rinitis
Matteo Gelardi,1 Giuseppe Porro,1 Nicola Quaranta,1 Brigida Sterlicchio,1 Michela Silvestri,2 Giorgio Ciprandi3
1University of Bari Aldo Moro, Department of Basic Medical Scien-
ce, Neuroscience and Sensory Organs, Bari, Italy
2Istituto Giannina Gaslini, Genoa, Italy
3Ospedale Policlinico San Martino, Genoa, Italy
How to cite this article: Gelardi M, Porro G, Quaranta N, Sterlicchio B, Silvestri M, Ciprandi G.The role of the fern
test in the treatment of rhinitis. Rev Alerg Mex. 2019;66(2):184-191
ORCID
Matteo Gelardi, 0000-0003-4406-0008; Giuseppe Porro, 0000-0003-2860-7608; Nicola Quaranta,
0000-0001-6214-2336; Brigida Sterlicchio, 0000-0002-6606-4811; Michela Silvestri, 0000-0003-4804-2421;
Giorgio Ciprandi, 0000-0001-7016-8421
Abstract
Background: The fern test is a method for assessing the characteristics of the nasal section in the
treatment of patients with mucous dysfunction of the airway.
Objective: The aim of this study was to investigate the role of the fern test in patients with rhinitis
and to assess the classifi cation of each type of rhinitis (types I-IV) in clinical practice.
Methods: A cross-sectional study, which included consecutive patients from a third level Rhinology
Unit, worked with 182 patients with rhinitis and 30 healthy subjects as control. The patients were
subdivided according to their type of rhinitis: allergic rhinitis (59), infectious rhinitis (32), polyps
(31), NARES (Non-allergic rhinitis with eosinophilia syndrome) (30) and NARNE (non-allergic
rhinitis with neutrophils) (30).
Results: The control subjects had only type I or II rhinitis, whereas patients with rhinitis usually
showed type III or IV. Allergic rhinitis and nasal polyps had the most serious deterioration according
to the fern test (type IV).
Conclusions: The fern test is effective for assessing mucus alterations in patients with rhinitis and
it could be included as a new parameter in the study of rhinitis as a potential biomarker of the
function of damaged epithelial cells.
Keywords: Rhinitis; Fern test; Infl ammation of the mucosa
Correspondence: Giorgio Ciprandi.
gio.cip@libero.it
Received: 2018-08-28
Accepted: 2019-01-24
DOI: 10.29262/ram.v66i2.544
185
http://www.revistaalergia.mx Rev Alerg Mex. 2019;66(2):184-191
Gelardi M et al. Role of the fern test in the treatment of rhinitis
Background
Mucus is a complex, viscoelastic, and adherent se-
cretion that is produced and secreted by specialized
goblet cells and mucous cells in the columnar epi-
thelia that line the lumen of all the mucosa that are
exposed to the external environment.1,2 In particular,
mucus covers the inner linings of organs of the re-
spiratory tract, the gastrointestinal tract, the repro-
ductive tract, and the ocular surface. The concept of
mucus is very old as its existence was already known
from the time of the Ancient Greeks: phlegm was
one of 4 humors. Mucus is widely produced in both
kingdoms, plant and animal.3
From a physiological point of view, mucus car-
ries out many protective functions for the underlying
epithelia, such as mucosal lubrication, which is use-
ful for material transport and cellular hydration of
epithelial cells, mainly in the respiratory tract, eyes
and mouth, which are exposed directly to the drying
evaporative effects of air, and it provides a barrier
against noxious agents and exposure to pathogens
by trapping them.4 It also works as a cleansing trans-
port, in which the external particles that are trapped
in the mucus layer can be eliminated from organ
cavities by cilia-facilitated expulsion of the mucus
layer5 and provides a selectively permeable gel layer
for the diffusion, exchange and absorption of gases
(eyes and lungs) and nutrients (gastrointestinal tract)
with the underlying epithelium.6
The rheology of nasal mucus deserves prop-
er attention in clinical practice.7,8 From a chemical
point of view, mucus should be seen as an integrat-
ed structure of biopolymers. The physical charac-
teristics of mucus are complex, for example; it is a
non-Newtonian uid, and its physical characteris-
tics range from a viscous liquid to an elastic solid.
Mucus can be measured considering its consistency
by viscosity (resistance to fl ow) and elasticity (stiff-
ness). It must be noted that impaired mucus rheolo-
gy may have signifi cance on its functions, including
lubrication, barrier, and defense against infective
agents and noxious substances.8
Resumen
Antecedentes: La prueba de “helecho” es un método que sirve para evaluar las características
de la secreción nasal en el tratamiento de pacientes con disfunción de la mocosa de la vía aérea.
Objetivo: El objetivo del presente estudio fue investigar el papel de la prueba de helecho en
pacientes con rinitis y evaluar la clasifi cación de cada tipo de rinitis (tipos I a IV) en la práctica
clínica.
Métodos: Estudio transversal en el que se incluyeron pacientes consecutivos de una unidad de
rinología de tercer nivel. Se incluyeron 182 pacientes con rinitis y 30 sujetos sanos como controles.
Los pacientes se subdividieron según el tipo de rinitis: alérgica (59), infecciosa (32), pólipos (31),
rinitis eosinofílica no alérgica (30) y rinitis no alérgica con neutrófi los (30).
Resultados: Los sujetos control solo presentaron rinitis tipo I o II, mientras que los pacientes con
rinitis generalmente mostraban tipo III o IV. La rinitis alérgica y los pólipos nasales tuvieron el
deterioro más grave según la prueba de helecho (tipo IV).
Conclusiones: La prueba de helecho es efectiva para evaluar las alteraciones del moco en
pacientes con rinitis y podría incluirse como un nuevo parámetro en el estudio de la rinitis como
biomarcador potencial de la función de las células epiteliales dañadas.
Palabras clave: Rinitis; Prueba de "helecho"; Infl amación de la mucosa
Abbreviations and acronyms
AR, allergic rhinitis
MGG, May-Grünwald-Giemsa
NARES, non-allergic rhinitis with eosinophilia
NARNE, non-allergic rhinitis with neutrop hils
http://www.revistaalergia.mx
186 Rev Alerg Mex. 2019;66(2):184-191
Gelardi M et al. Role of the fern test in the treatment of rhinitis
Mucus is a thixotropic gel that is able to proper-
ly respond to shear stress. This ability depends on its
composition. The components of mucus are mucins,
DNA fragments, lipids, ions, proteins, cells, cellu-
lar debris, and water.9,10 In this regard, mucins are
the most important component of the mucus as it is
formed by cross-linked, bundled, and entangled mu-
cin fi bers which are produced and secreted by both
goblet cells and sero-mucinous glands.
The bio-rheological properties of the nasal mu-
cus are the cohesive forces, the load-bearing capaci-
ty, the spinnability, the thixotropy, the creep, and the
adhesiveness. This complexity may easily explain
how disorders could signifi cantly affect the compo-
sition and function of nasal mucus. Infections, in-
ammatory disorders (including allergic and non-al-
lergic infi ltrates), polyps, drugs, and primary mucus
defects may signifi cantly alter the composition and
function of mucus.
The properties of mucus may be assessed by
using sophisticated tests, but a simple way could be
represented by the nasal cytology. Long time ago,
Papanicolaou proved that some cervical mucus that
was spread on a slide and left to dry was able to
crystallize with a characteristic shape, like an “ar-
borization”: a fern-like reaction.11 He brilliantly con-
ceived that this phenomenon could depend on the
ovulation time as a refl ection of the estrogenic activ-
ity that was able to affect the characteristics of the
mucus. Further on, it was proven, by inducing the
mucus-fern phenomenon,12,13 that the alterations of
mucus, depending on the cycle of sexual hormones,
occurred also in other mucus-secreting surfaces of
the body; including the nose, salivary glands, and
lacrimal glands. Abou-Shabanah and Plotz proved
that the fern reaction depended on electrolyte, pro-
tein and/or saccharide concentrations.14 So, the fern
test was used to assess the characteristics of mucus
in several disorders. Rolando et al. defi ned a scoring
system to assess the fern test15 and reported fern im-
pairment in different disorders at an ocular level.16,17
These outcomes were confi rmed by further studies
that were always conducted at an ocular level,18,19 so
the fern test is commonly used in clinical practice in
an ophthalmological setting. However, only another
study considered the fern phenomenon in the nose:
it compared nasal and cervical mucus. The authors
concluded that mucus is an ancestral biological
component, but they did not speculate about nasal
disorders.20 Thus, we aimed to investigate the role
of the fern test in patients with rhinitis in clinical
practice.
Methods
Globally, 182 consecutive patients (102 males and
80 females, mean age: 43.15 ± 19.03 years) with
rhinitis were visited at the Rhinology Unit because
of their intensive treatment and they were included
in this study.
The inclusion criteria were:
Adult men and women.
Documented diagnosis of rhinitis, including al-
lergic rhinitis, infectious rhinitis, non-allergic
rhinitis (NARES or NARNE), or nasal polyps.
Presence of nasal symptoms.
The exclusion criteria were:
Concomitant comorbidities and chronic illness-
es that could interfere in the interpretation of the
ndings.
Current treatments able to interfere in the inter-
pretation of the fi ndings. In addition, 30 healthy
subjects were included in the study.
The Review Board approved the procedure
and a written informed consent was given by all
participants.
A nasal endoscopy was carried out with a 3.4
mm diameter fl exible fi beroscope (Vision-Sciences®
ENT-2000) to assess the nasal cavities.
Nasal cytology involves: sampling, processing
and microscope reading. The sampling requires the
collection of cells from the surface of nasal mucosa,
which is done by a sterile disposable curette. Sam-
ples should be collected from the middle portion of
the inferior turbinate. The procedure is performed
under anterior rhinoscopy, with an appropriate light
source, and the procedure is completely painless. The
obtained sample is smeared immediately on a glass
slide and it is air-dried. The sample staining is carried
out by using the common May-Grünwald-Giemsa
(MGG) staining because of its ability to correctly
identify the infl ammatory nasal cells. The traditional
MGG staining procedure requires about 30 minutes.
The stained sample is read at optical microscopy,
with a 1000x objective with oil immersion. Fifty is
187
http://www.revistaalergia.mx Rev Alerg Mex. 2019;66(2):184-191
Gelardi M et al. Role of the fern test in the treatment of rhinitis
the minimum number of elds in order to identify
a suffi cient number of cells. The count of each cell
type was expressed by a semi-quantitative grading
as it was described previously.21 The detection of eo-
sinophils, mast cells, bacteria or fungal ifae clearly
identifi es a pathological condition. In nasal cytolo-
gy, bacterial infectious rhinitis is usually character-
ized by the presence of many neutrophils, with intra
and extracellular bacteria that can be easily identi-
ed at optical microscopy. Lymphocytes and mac-
rophage can accompany the neutrophilic infi ltrate.22
Allergic rhinitis (AR) is always characterized by the
presence of infl ammatory cells (eosinophils, mast
cells, neutrophils, and lymphocytes) in the nose.
Non-allergic infl ammatory rhinitis is defi ned by the
presence of infl ammatory cells in the nasal muco-
sa and by the absence of allergic sensitization. The
best known and rst described non-allergic rhinitis
was NARES: the presence of eosinophils is not only
predominant but also massively present with an ex-
pression that is even higher than in seasonal rhinitis.
Another important type of infl ammatory non-aller-
gic rhinitis is NARNE; which is characterized by a
massive presence of neutrophils without concomi-
tant bacterial colonization.23 Nasal polyps may show
an infl ammatory pattern, as previously reported.24
For the fern test, nasal specimens were taken,
as well as the traditional nasal cytology. The collect-
ed smears were put on microscope slides and left to
dry at room temperature for 10 minutes. They were
examined under a phase contrast microscope at 100×
and 400× magnifi cation and they were classifi ed from
type I to type IV according to the Rolando scoring.25
In type I (normal pattern), the fern pattern is uniform
with closely branching arborization. In type II, the
ferns are well distinguished but with less branching.
In type III, there are scattered ferns with rare branch-
ing, and, in type IV, no fern pattern is seen.
Statistical analysis
Descriptive statistics were performed and reported
in terms of absolute frequencies or percentages for
qualitative data and in terms of medians with rst
and third quartiles (1q-3q) or means with standard
deviation for quantitative data. The comparison of
frequency distributions was made by means of the
chi-square test or the Fisher’s exact test in case of
expected frequencies < 5. All tests were two-tailed,
and p-values < 0.05 have been considered statisti-
cally signifi cant. The analyses were performed using
the GraphPad Prism software, GraphPad Software
Inc, CA, USA
Results
Table 1 reports demographic and clinical character-
istics of control and patients with different types of
Table 1. Demographic and clinical characteristics of controls and patients with rhinitis
Controls
(30)
Patients with
rhinitis
(182)
Allergic
rhinitis
(59)
Infectious
rhinitis
(32)
Nasal polyps
(31)
NARES
(30)
NARNE
(30)
Age
(mean ± SD) 37.63 ± 17.87 43.15 ± 19.03 38.29 ± 18.46 35.75 ± 20.36 56.39 ± 11.57 48.93 ± 16.38 41.13 ± 19.84
Sex
(male/female) 15/15 102/80 3/27 16/16 19/12 17/13 16/14
n%n%n%n%n%n%n%
Allergy 0 0 89 48.90 59 66.29 10 11.24 12 13.48 5 5.62 3 3.37
ASA
sensitivity 0 0 20 10.98 1 5.00 3 15.00 10 50.00 4 20.00 2 10.00
Asthma 0 0 31 17.03 10 32.26 5 16.13 10 32.26 4 12.90 2 6.45
Smoke 0 0 59 32.40 11 18.64 14 23.73 11 18.64 12 20.34 11 18.64
Current 48 26.40 9 81.82 12 85.71 8 72.73 10 83.33 9 81.82
Past 11 6.04 2 18.18 2 14.29 3 27.27 2 16.67 2 18.18
NP = nasal polyps, NARES = non-allergic rhinitis with eosinophils, NARNE = non-allergic rhinitis with neutrophils, SD = standard deviation,
ASA = acetylsalicylic acid
http://www.revistaalergia.mx
188 Rev Alerg Mex. 2019;66(2):184-191
Gelardi M et al. Role of the fern test in the treatment of rhinitis
rhinitis. Allergic rhinitis was the most frequently di-
agnosed type of rhinitis (59 out of 182); all the other
types of rhinitis i.e. infectious, polyposis, NARNE,
NARES were found almost equally among patients.
Allergy was a common comorbidity, ASA sensi-
tivity was more frequently present in patients with
nasal polyps, asthma was more commonly reported
in patients with allergic rhinitis and nasal polyps, and
smoking was reported in about 1/3 of patients.
Considering nasal specimens, we found that
type II was the most common one in control subjects
(76.67 %), whereas type III (59.34 %), followed by
type IV (28.02 %), was the most frequently observed
among patients with rhinitis (fi gure 1 and table 2). It
is worthy of note that no control subject had a type
III or type IV fern pattern. The frequency of differ-
ent fern patterns was signifi cantly different among
patients with different types of rhinitis and control
subjects (p = 0.0066).
In type I fern patterns, only 12.5 % of nasal
specimens were collected from patients with rhini-
tis (i.e. infectious); all the other were isolated from
control subjects (87.5 %) (fi gure 2). More than half
of the nasal specimens characterized by type II fern
pattern were collected from control subjects, where-
as the remaining specimens were recovered from pa-
tients with allergic rhinitis, infectious rhinitis, NA-
RES or NARNE (fi gure 2). Allergic rhinitis was the
most frequent type of rhinitis (37.96 %), followed
by infectious (19.44 %) associated to a type III fern
pattern. Differently, considering type IV, about 30 %
and 25 % of this pattern was found in patients with
nasal polyps or in patients with allergic rhinitis, re-
spectively (fi gure 2).
We also observed that the type of rhinitis that
was most commonly found in the most “pathologic”
fern patterns, i.e. type III or type IV, was allergic rhi-
nitis, which affected about 1/3 of the patients whose
specimens had type III or type IV fern patterns. The
other 2/3 were almost equally distributed among the
other types of rhinitis (fi gure 3).
In order to verify possible differences in fern
patterns between control subjects and patients with
rhinitis, we analyzed each type of rhinitis separate-
ly. Patients with infectious rhinitis, with NARNE
or with allergic rhinitis had a type III fern pattern
more frequently, whereas control subjects had a type
II pattern more frequently (p < 0.0001, each com-
parison), (data not shown). In patients with NARES
or nasal polyps, type III and type IV were the most
frequent patterns whereas, in control subjects, type
II was predominant (p < 0.0001, each comparison).
No statistically signifi cant difference in fern
patterns was found in patients with different de-
Figure 1. The four grades
of nasal ferning taken at
100x magnifi cation, classi-
ed from type I to type IV
according to the Rolando
scoring.25 Panel A, type I
(normal pattern): the fern-
ing pattern is uniform with
closely branching arboriza-
tion. Panel B, type II: the
ferns are well distinguished
but with less branching.
Panel C, type III: there are
scattered ferns with rare
branching. Panel D, type
IV: no ferning pattern is
seen. Light microscope at
400× magnifi cation.
189
http://www.revistaalergia.mx Rev Alerg Mex. 2019;66(2):184-191
Gelardi M et al. Role of the fern test in the treatment of rhinitis
grees of nasal eosinophilia or neutrophilia (data
not shown).
Discussion
The defi nition of rhinitis assumes the concept of an
infl ammatory reaction; the characteristics of nasal
infl ammation, mainly regarding the peculiar cellular
infi ltrate, allow the differentiation of several types of
rhinitis. However, a common denominator in infl am-
matory disorders is the presence of impaired mucus.
Altered mucus is per se a pathogenic factor that in-
duces a vicious circle that involves a deterioration of
infl ammatory disorders.
Nasal cytology is commonly used in clinical
practice to defi ne the type of rhinitis, to quantify
the cellular infi ltrate, and to monitor infl ammatory
change over time.21 Traditionally, the nasal cytolo-
gy assessment considers cellular presence and mor-
phology, bacteria, and biofi lm. However, mucus is a
component that is neglected in the treatment of nasal
disorders. A possible explanation is the complexity
of diagnostic tests able to assess the characteristics
of mucus.
In this regard, the fern test could be a very
simple and useful method to investigate mucus in
patients with rhinitis. The current study, conducted
in a real-world setting, such as a Rhinology Unit,
proved that rhinitis is associated with impaired fern
patterns. In particular, healthy subjects have only
type I or II fern patterns and never III or IV. On the
Table 2. Frequency of different ferning Types within each rhinitis group
Study groups Disease
Ferning type
I II III IV
n%n%n%n%
Patients with
rhinitis
1 0.55 22 12..09 108 59.34 51 28.02
Allergic rhinitis 0 0 5 8.47 41 69.49 13 22.03
Infectious rhinitis 1 3.13 5 15.63 21 65.63 5 15.63
NARES 0 0 5 16.67 12 40 13 43.33
NARNE 0 0 7 23.33 18 60 5 16.67
nasal polyps 0 0 0 0 16 51.61 15 48.39
Control subjects 7 23.33 23 76.67 0 0 0 0
NARES = non-allergic rhinitis with eosinophils, NARNE = non-allergic rhinitis with neutrophils.
Figure 2. Frequency of
different rhinitis within
each ferning type.
100
90
80
70
60
50
40
30
20
10
0
Control subjects
Polyposis
NARNE
NARES
Infectious rhinitis
Allergic rhinitis
87.5
12.5 11.11
11.11
11
15.56
51.11
14.81
16.67
11
19.44
37.96 25.49
9.8
9.8
29.41
25
I II III IV
Ferning (type)
Percentage
http://www.revistaalergia.mx
190 Rev Alerg Mex. 2019;66(2):184-191
Gelardi M et al. Role of the fern test in the treatment of rhinitis
other hand, patients with rhinitis frequently present
type III or IV fern patterns. Allergic rhinitis and na-
sal polyps are most frequently associated with type
IV fern patterns. This fi nding could depend on more
intense infl ammation, even though a clear-cut rela-
tionship between cellular infi ltrate and fern pattern
was not reported.
The most relevant outcome of the present study
is the feasibility of the fern test in the treatment of
patients with rhinitis. The fern test may be consid-
ered a reliable tool for assessing the characteristics
of the mucus, and its ndings have clinical rele-
vance. It is conceivable that impaired fern patterns,
such as type III and IV, could be the expression of
damaged epithelial cells, mainly concerning mu-
ciparous cells. In fact, patients with rhinitis usually
present altered fern patterns. In other words, type I
(and type II) fern patterns could mean the wellness
of the epithelium.
However, the present study has some limita-
tions, including the cross-sectional design, the lack
of mediator’s assessment, and the lack of assessment
of clinical symptoms. Therefore, other studies should
be designed to fulfi ll these unmet needs. In particu-
lar, it is necessary to correlate the severity of nasal
disorders with the type of fern patterns. If a strong re-
lationship between the type of fern pattern and severe
symptoms and/or infl ammatory aspects exists, this
test could be fruitful in phenotyping patients with
rhinitis. Therefore, the fern test could be considered
a potential biomarker that is useful for defi ning epi-
thelial damage in nasal disorders. This issue should
be properly investigated in further studies.
In conclusion, the fern test could be considered
a fruitful method to assess mucus alterations in pa-
tients with rhinitis and it could be included as a new
parameter in the treatment of rhinitis as a potential
biomarker of damaged epithelial cell function.
References
1. Bansil R, Turner BS. The biology of mucus: composition, synthesis and organization. Adv Drug Deliv
Rev. 2018;124:3-15. DOI: 10.1016/j.addr.2017.09.023
2. Taherali F, Varum F, Basit AW. A slippery slope: on the origin, role and physiology of mucus. Adv Drug
Deliv Rev. 2018;124:16-33. DOI: 10.1016/j.addr.2017.10.014
3. Lang T, Klasson S, Larsson E, Johansson ME, Hansson GC, Samuelsson T. Searching the evolutionary
origin of epithelial mucus protein components-mucins and FCGBP. Mol Biol Evol. 2016;33(8):1921-
1936. DOI: 10.1093/molbev/msw066
4. Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev. 2009;61(2):75-85. DOI: 10.1016/j.
addr.2008.09.008
5. Silberberg A. On mucociliary transport. Biorheology. 1990;27(3-4):295-307. DOI: 10.3233/BIR-1990-
273-408
33.96 %
19.5 %
16.35 %
15.72 % 14.47 %
0%
Allergic rhinitis
Nasal polyposis
Infectious rhinitis
NARES
NARNE
Control subjects
Figure 3. Frequency of different rhinitis in fern-
ing type III or IV.
191
http://www.revistaalergia.mx Rev Alerg Mex. 2019;66(2):184-191
Gelardi M et al. Role of the fern test in the treatment of rhinitis
6. Neutra MR, Forstner JF. Gastrointestinal mucus: synthesis, secretion, and function. In: Johnson LR
(editor). Physiology of the gastrointestinal tract. EEUU: Raven Press; 1987.
7. Quraishi MS, Jones NS, Mason J. The rheology of nasal mucus: a review. Clin Otolaryngol Allied Sci.
1998;23(5):403-413. DOI: 10.1046/j.1365-2273.1998.00172.x
8. Lai SK, Wang YY, Wirtz D, Hanes J. Micro- and macrorheology of mucus. Adv Drug Deliv Rev.
2009;61(2):86-100. DOI: 10.1016/j.addr.2008.09.012
9. Carlstedt I, Sheehan JK. Structure and macromolecular properties of cervical mucus glycoproteins.
Symp Soc Exp Biol. 1989;43:289-316.
10. Thornton DJ, Sheehan JK. From mucins to mucus: toward a more coherent understanding of this
essential barrier. Proc Am Thorac Soc. 2004;1(1):54-61. DOI: 10.1513/pats.2306016
11. Papanicolaou GN. Mucus test. Anat Rec. 1945;91:293.
12. Roland M. A simple test for the determination of ovulation, estrogen activity, and early pregnancy
using the cervical mucus secretion; a preliminary report. Am J Obstet Gynecol. 1952;63(1):81-89. DOI:
10.1016/S0002-9378(16)38983-9
13. Zondek B, Rozin S. Cervical mucus arborization; its use in the determination of corpus luteum function.
Obstet Gynecol. 1954;3(5):463-470. DOI: 10.1097/00006254-195508000-00049
14. Abou-Shabanah EH, Plotz EJ. A biochemical study of the cervical and nasal mucus fern phenomenon.
Am J Obs Gynecol. 1957;74(3):559-568. DOI: 10.1016/0002-9378(57)90508-2
15. Rolando M. Tear mucus ferning test in normal and keratoconjunctivitis sicca eyes. Chibret Int J
Ophthalmol. 1984;2:33-41.
16. Rolando M, Baldi F, Zingirian M. The effect of hyperosmolarity on tear mucus ferning. Fortschr
Ophthalmol. 1986;83(6):644-646.
17. Rolando M, Baldi F, Calabria G. Tear mucus crystallization in children with cystic brosis. Ophthalmologica.
1988;197(4):202-206. DOI: 10.1159/000309944
18. Kalayci D, Kiper N, Ozcelik U, Gocmen A, Hasiripi H. Clinical status, ocular surface changes and tear
ferning in patients with cystic brosis. Acta Ophthalmol Scand. 1996;74(6):563-565. DOI: 10.1111/j.1600-
0420.1996.tb00735.x
19. Horwath J, Ettinger K, Bachernegg M, Bodner E, Schmut O. Ocular Ferning Test - effect of temperature
and humidity on tear Ferning patterns. Ophthalmologica. 2001;215(2):102-107. DOI: 10.1159/000050838
20. Lavaud MC, Trouillas J. The mucus: a medium of life. Gynecol Obstet Fertil. 2012;40(1):19-23. DOI:
10.1016/j.gyobfe.2011.07.031
21. Gelardi M. Atlas of nasal cytology. Second edition. Milan, Italy: Edi Ermes; 2012.
22. Gelardi M, Fiorella ML, Russo C, Fiorella R, Ciprandi G. Role of nasal cytology. Int J Immunopathol
Pharmacol. 2010;23(Suppl 1):45-49.
23. Gelardi M, Maselli-Del-Giudice A, Fiorella ML, Fiorella R, Russo C, Soleti P, et al. Non-allergic rhinitis
with eosinophils and mast cells constitutes a new severe nasal disorder. Int J Immunopathol Pharmacol.
2008;21(2):325-331. DOI: 10.1177/039463200802100209
24. Gelardi M, Iannuzzi L, De-Giosa M, Taliente S, DeCandia N, Quaranta N,et al. Non-surgical management
of chronic rhinosinusitis with 1 nasal polyps based on clinical cytological grading: a precision medicine-
based approach. Acta Otorhinolaryngol Ital. 2017;37(1):38-45. DOI: 10.14639/0392-100X-1417
25. Rolando M. Tear mucus ferning test in normal and keratoconjunctivitis sicca eyes. Chibret Int J
Ophthalmol. 1984;2:32-41.
... El test de cristalización o helecho es un método muy utilizado de rutina en los servicios de ginecología para el diagnóstico de ruptura prematura de membrana (RPM) (1) . Sin embargo, también se ha demostrado que es útil para evaluar las alteraciones del moco en pacientes con rinitis (2) . Según el protocolo de SEGO del 2004, el 80% de los casos de RPM se presentaron en gestaciones a término, y el 20% son de gestaciones pretérmino, resaltando su importancia como causa de morbimortalidad perinatal, por lo que su correcto diagnóstico es crucial para adoptar un tratamiento adecuado, el cual está basado generalmente en la anamnesis y la exploración física. ...
... Es importante mencionar que esta prueba también podría incluirse como una alternativa de apoyo diagnóstico en el estudio de la rinitis como biomarcador potencial de la función de las células epiteliales dañadas (2) . ...
... Meanwhile, it can also promote vasoconstriction, reduce vascular permeability, and relieve mucosal congestion and edema [27]. Therefore, the application of glucocorticoids postoperatively is considered to be an effective response to the inflammatory reaction caused by wound injury after endoscopic sinus surgery [28]. This study investigated and analyzed the effects of glucocorticoid infiltration on chronic rhino-sinusitis with nasal polyps (CRSwNP) after ESS and its curative efficacy on nasal ventilation and MCC. ...
Article
Objectives: This study investigated and analyzed the effects of glucocorticoid infiltration on chronic rhino-sinusitis with nasal polyps (CRSwNP) after endoscopic sinus surgery (ESS) and its curative efficacy on nasal ventilation function and mucociliary clearance (MCC). Methods: 126 CRSwNP patients admitted to the hospital from March 2018 to May 2020 were enrolled and randomly divided into observation group (n=65) and control group (n=61) based on random number table. The control group received ESS, and the observation group was given glucocorticoids treatment after ESS. The changes of nasal ventilation function, MCC and quality of life between the two groups of patients before and after treatment were compared. Results: The overall effective rate of clinical therapy was critically higher in observation group than in control group (P<0.05). In addition, NMCA and NCV in observation group were critically higher than those in control group (P<0.05), and nasal airway resistance (NAR) in observation group was notably lower than that in control group (P<0.05). In addition, the Saccharin removal time in observation group after treatment was remarkably lower than that in control group (P<0.05), while the speed and rate of MCC were critically higher than those in control group (P<0.05). Finally, the scores of each dimension of WHOQOL-100 scale in two groups of subjects after treatment were critically higher than those before treatment (P<0.05), and the scores in observation group were notably higher than those in control group (P<0.05). Conclusion: The treatment of glucocorticoid infiltration on CRSwNP after ESS can effectively improve the curative effect. It improves the patient's function of nasal ventilation and MCC, thus beneficial to promoting the sufferers' living quality and is worthy of clinical promotion.
Article
Secretory senescence of the upper and lower airway represents the most important risk factor for respiratory complication in the elderly. In most cases, patients present with high health care costs due to the relevant number of hospitalizations and medical cares. A growing evidence is accumulating on the role of immunosenescence in the pathogenesis of chronic rhinosinusal disorders, and on defect in the lubrication of the corneal, conjunctival and scleral mucosa, delicate structures of the external eye, and of trachea-bronchial diseases, de-pendent on a failure of the gland system and reduction of mucociliary clearance (MCC). The presence of multiple comorbidities in the elderly may significantly contribute to a systemic pro-inflammatory state which negatively affects the airway. Secretory senescence promotes systemic inflammation and exacerbates the pre-existing pathologies. The role of cytokines is associated to a pro-inflammatory state of breathing apparatus. Several observations support the hypothesis that the secretory senescence can act in a paracrine and vasocrine manner to influence the structure and function of glands, mucus and lacrimal secretions, thus contributing to fraility and hospitalizations in the elderly. Given the recognized role of secretory senescence in the pathophysiology of airway disease, it should be desirable to identify specific therapies targeting the nasal, lacrimal and tracheo-bronchial secretory system able to modulate its pro-inflammatory profile and the negative effect of the inflammatory burden on the elderly.
Article
Full-text available
La rinosinusite cronica con polipi nasali (CRSwNP) è una malattia cronica nasosinusale, a eziologia infiammatoria, con significativo impatto negativo sulla qualità di vita dei pazienti. La CRSwNP rappresenta ancora oggi una sfida terapeutica per lo specialista ORL, sia per la comprensione della sua eziopatogenesi, sia per il suo controllo clinico ed è questo è testimoniato dalla alta incidenza di recidiva dopo trattamento. Abbiamo voluto verificare l’ipotesi che un approccio terapeutico nuovo, standardizzato, e individualizzato sul grading clinico-citologico (clinical-cytological grading – CCG) consentisse un miglior controllo dei sintomi della malattia, e di ridurre la necessità di ricorrere alla chirurgia. Abbiamo pertanto reclutato 204 pazienti affetti da CRSwNP, di cui 145 hanno regolarmente assunto la terapia rispettando il protocollo proposto, e 59 pazienti, invece, che non hanno assunto la terapia in modo sistematico e sono stati quindi inclusi come controlli. Dopo 5 anni di trattamento standardizzato, abbiamo notato che 15 pazienti su 145 (10,3%) del gruppo con terapia standardizzata avevano avuto un miglioramento dello staging endoscopico, 61 su 145 (42%) si erano mantenuti costanti, mentre 69/145 (47,5%) erano andati incontro a un peggioramento. Nel gruppo di controllo, invece, i pazienti peggiorati erano ben 49 su 59 (83%), con un peggioramento significativo in termini di grading endoscopico di almeno due classi (p < 0,05). I pazienti e i controlli sono stati successivamente stratificati sulla base del CCG in 3 sottogruppi: pazienti con CCG lieve, moderata e grave. Dopo tale suddivisione in classi, è stato possibile evidenziare che nel gruppo con CCG lieve (n = 27), il 92% dei pazienti manteneva negli anni un trend costante, in assenza di peggioramenti e senza necessità di ricorrere alla chirurgia nei 5 anni di osservazione, mentre nel gruppo di controllo, 1 paziente su 59 (1,6%; p
Article
Full-text available
The gel-forming mucins are large glycosylated proteins that are essential components of the mucus layers covering epithelial cells. Using novel methods of identifying mucins based on profile hidden Markov models, we have found a large number of such proteins in Metazoa, aiding in their classification and allowing evolutionary studies. Most vertebrates have 5–6 gel-forming mucin genes and the genomic arrangement of these genes is well conserved throughout vertebrates. An exception is the frog Xenopus tropicalis with an expanded repertoire of at least 26 mucins of this type. Furthermore, we found that the ovomucin protein, originally identified in chicken, is characteristic of reptiles, birds, and amphibians. Muc6 is absent in teleost fish, but we now show that it is present in animals such as ghost sharks, demonstrating an early origin in vertebrate evolution. Public RNA-Seq data were analyzed with respect to mucins in zebrafish, frog, and chicken, thus allowing comparison in regard of tissue and developmental specificity. Analyses of invertebrate proteins reveal that gel-forming-mucin type of proteins is widely distributed also in this group. Their presence in Cnidaria, Porifera, and in Ctenophora (comb jellies) shows that these proteins were present early in metazoan evolution. Finally, we examined the evolution of the FCGBP protein, abundant in mucus and related to gel-forming mucins in terms of structure and localization. We demonstrate that FCGBP, ubiquitous in vertebrates, has a conserved N-terminal domain. Interestingly, this domain is also present as an N-terminal sequence in a number of bacterial proteins.
Article
Full-text available
Nasal cytology represents a valid method in the differential diagnosis of allergic and non-allergic nasal diseases, as it is simple, safe, non-invasive, cost-effective, and easy to perform both in the medical and paediatric office. In particular, through cytological investigation it is possible to diagnose a group of non-allergic infective rhinitis that still today constitutes a vague aspect of the clinical-diagnostic-therapeutic approach to eosinophilic non-allergic rhinitis (NARES), non-allergic rhinitis mast cell (NARMA), neutrophilic non-allergic rhinitis (NARNA), and eosinophil-mast cell non-allergic rhinitis (NARESMA). Preventive treatment of nasal diseases, when guided by rhinocytograms, leads to a favorable clinical and time-dependent outcome. These advantages are reflected in a better quality of life and in a reduction in National Health Service costs, without chronic evolution of the disease to complications.
Article
The mucosa of the gastrointestinal tract, eyes, nose, lungs, cervix and vagina is lined by epithelium interspersed with mucus-secreting goblet cells, all of which contribute to their unique functions. This mucus provides an integral defence to the epithelium against noxious agents and pathogens. However, it can equally act as a barrier to drugs and delivery systems targeting epithelial passive and active transport mechanisms. This review highlights the various mucins expressed at different mucosal surfaces on the human body, and their role in creating a mucoid architecture to protect epithelia with specialized functions. Various factors compromising the barrier properties of mucus have been discussed, with an emphasis on how disease states and microbiota can alter the physical properties of mucus. For instance, Akkermansia muciniphila, a bacterium found in higher levels in the gut of lean individuals induces the production of a thickened gut mucus layer. The aims of this article are to elucidate the different physiological, biochemical and physical properties of bodily mucus, a keen appreciation of which will help circumvent the slippery slope of challenges faced in achieving effective mucosal drug and gene delivery.
Article
In this review we discuss mucus, the viscoelastic secretion from goblet or mucous producing cells that lines the epithelial surfaces of all organs exposed to the external world. Mucus is a complex aqueous fluid that owes its viscoelastic, lubricating and hydration properties to the glycoprotein mucin combined with electrolytes, lipids and other smaller proteins. Electron microscopy of mucosal surfaces reveals a highly convoluted surface with a network of fibers and pores of varying sizes. The major structural and functional component, mucin is a complex glycoprotein coded by about 20 mucin genes which produce a protein backbone having multiple tandem repeats of Serine, Threonine (ST repeats) where oligosaccharides are covalently O-linked. The N- and C-terminals of this apoprotein contain other domains with little or no glycosylation but rich in cysteines leading to dimerization and further multimerization via S-S bonds. The synthesis of this complex protein starts in the endoplasmic reticulum with the formation of the apoprotein and is further modified via glycosylation in the cis and medial golgi and packaged into mucin granules via Ca(2+) bridging of the negative charges on the oligosaccharide brush in the trans golgi. The mucin granules fuse with the plasma membrane of the secretory cells and following activation by signaling molecules release Ca(2+) and undergo a dramatic change in volume due to hydration of the highly negatively charged polymer brush leading to exocytosis from the cells and forming the mucus layer. The rheological properties of mucus and its active component mucin and its mucoadhesivity are briefly discussed in light of their importance to mucosal drug delivery.
Article
To investigate whether mucus, with its complex structure and specific functional properties, is a medium for life? We compared cervical and nasal mucus samples collected from 45 ovulatory women consulting for sterility and 5 menopausal women respectively. We analyzed the physicochemical and functional characteristics. We also performed 266 sperm penetrability tests. We studied 32 samples using scanning electron microscope, according to Hexamethyl-Disilasane technique and the critical point drying method. Both types of mucus had 10cm spin abilities and typical ferning patterns. The pH were similar (8.09±0.58 and 8.46±0.32 for cervical and nasal mucus, respectively) as well as the percentages of positive sperm penetration test (55.6 and 40.6 respectively). We observed similar patterns of spermatozoa mobility in both types of mucus. Under the scanning electron microscope, structures resembled woven fabric, with a stretched and rigid framework. Filaments of different diameters formed variable loose meshes. Thinner filaments linked together thicker filaments measuring between 300 and 400nm. The intermediate filaments varied between 100 and 200nm. Very thin and sparse filaments crossed the meshes, measuring between 10 to 100nm. Spermatozoa, bacteria and unspecified round cells were enmeshed in the mucus. From this first comparative study of nasal and cervical mucus giving the proof of sperm penetration in the both mucus and the discovery of mucus produced by archaea living in extreme conditions, we suggested that mucus, from all origins, is a medium of life.
Article
Mucus is a complex biological material that lubricates and protects the human lungs, gastrointestinal (GI) tract, vagina, eyes, and other moist mucosal surfaces. Mucus serves as a physical barrier against foreign particles, including toxins, pathogens, and environmental ultrafine particles, while allowing rapid passage of selected gases, ions, nutrients, and many proteins. Its selective barrier properties are precisely regulated at the biochemical level across vastly different length scales. At the macroscale, mucus behaves as a non-Newtonian gel, distinguished from classical solids and liquids by its response to shear rate and shear stress, while, at the nanoscale, it behaves as a low viscosity fluid. Advances in the rheological characterization of mucus from the macroscopic to nanoscopic levels have contributed critical understanding to mucus physiology, disease pathology, and the development of drug delivery systems designed for use at mucosal surfaces. This article reviews the biochemistry that governs mucus rheology, the macro- and microrheology of human and laboratory animal mucus, rheological techniques applied to mucus, and the importance of an improved understanding of the physical properties of mucus to advancing the field of drug and gene delivery.
Article
Mucus is tenacious. It sticks to most particles, preventing their penetration to the epithelial surface. Multiple low-affinity hydrophobic interactions play a major role in these adhesive interactions. Mucus gel is also shear-thinning, making it an excellent lubricant that ensures an unstirred layer of mucus remains adherent to the epithelial surface. Thus nanoparticles (NP) must diffuse readily through the unstirred adherent layer if they are to contact epithelial cells efficiently. This article reviews some of the physiological and biochemical properties that form the mucus barrier. Capsid viruses can diffuse through mucus as rapidly as through water and thereby penetrate to the epithelium even though they have to diffuse 'upstream' through mucus that is being continuously secreted. These viruses are smaller than the mucus mesh spacing, and have surfaces that do not stick to mucus. They form a useful model for developing NP for mucosal drug delivery.